See every side of every news story
Published loading...Updated

FDA OKs Dust Mite Allergy Drug for Young Kids

Summary by MedPage Today
(MedPage Today) -- The FDA expanded the approval of a sublingual immunotherapy (SLIT; Odactra) for treating house dust mite allergies in young children, drugmaker ALK announced. Taken as a once-daily tablet, the SLIT product is now indicated for...

4 Articles

All
Left
Center
1
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

drugtopics.com broke the news in on Friday, February 28, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.